[1] [1] Zolpidem[EB/OL]. (2024-04-15). https://go.drugbank.com/drugs/DB00425.

[2] [2] SALV P, COSTA J. Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications[J]. Clin Pharmacokinet, 1995, 29(3): 142−153. doi: 10.2165/00003088-199529030-00002.

[4] [4] DROVER D R. Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: Zaleplon, zolpidem and zopiclone[J]. Clin Pharmacokinet, 2004, 43(4): 227−238. doi: 10.2165/00003088-200443040-00002.

[5] [5] MONTI J M, SPENCE D W, PANDI-PERUMAL S R, et al. Pharmacotherapy of insomnia: Focus on zolpidem extended release[J]. Clin Med Ther, 2009, 1(5): 123−140. doi: 10.4137/cmt.s2040.

[10] [10] EDINOFF A N, WU N, GHAFFAR Y T, et al. Zolpidem: Efficacy and side effects for insomnia[J]. Health Psychol Res, 2021, 9(1): 24927. doi: 10.52965/001c.24927.

[12] [12] GUO T, MAO G, ZHAO L, et al. Comparative pharmacokinetics of zolpidem tartrate in five ethnic populations of China[J]. Acta Pharm Sin B, 2014, 4(2): 146−150. doi: 10.1016/j.apsb.2014.02.001.

[13] [13] SCHULZ M, IWERSEN-BERGMANN S, ANDRESEN H, et al. Therapeutic and toxic blood concentrations of nearly 1, 000 drugs and other xenobiotics[J]. Crit Care, 2012, 16(4): R136. doi: 10.1186/cc11441.

[14] [14] SCHULZ M, SCHMOLDT A, ANDRESEN-STREICHERT H, et al. Revisited: Therapeutic and toxic blood concentrations of more than 1 100 drugs and other xenobiotics[J]. Crit Care, 2020, 24(1): 195. doi: 10.1186/s13054-020-02915-5.

[15] [15] HASEGAWA K, WURITA A, NOZAWA H, et al. Fatal zolpidem poisoning due to its intravenous self-injection: Postmortem distribution/redistribution of zolpidem and its predominant metabolite zolpidem phenyl-4-carboxylic acid in body fluids and solid tissues in an autopsy case[J]. Forensic Sci Int, 2018, 290: 111−120. doi: 10.1016/j.forsciint.2018.06.044.

[17] [17] LAI S W, LIN C L, LIAO K F. Increased relative risk of acute pancreatitis in zolpidem users[J]. Psychopharmacology (Berl), 2015, 232(12): 2043−2048. doi: 10.1007/s00213-014-3833-6.

[18] [18] DA SILVA V C S, BITTENCOURT P L, PINHO S, et al. Delayed-onset hepatic encephalopathy induced by zolpidem: A case report[J]. Clinics (Sao Paulo), 2008, 63(4): 565−566. doi: 10.1590/s1807-59322008000400028.